Breakthrough Cancer Test: Can It Detect Cancer Earlier Than Ever Before?

Breakthrough Cancer Test: Can It Detect Cancer Earlier Than Ever Before?

Welcome to MedHeads! In this episode, Dr. Ferghal Armstrong sits down with Mohan Uttawar, CEO of One Cell AI, to explore how liquid biopsies and single-cell technology are revolutionizing cancer detection and treatment.

Discover how a simple blood test can now identify circulating tumor cells (CTCs)—offering a faster, less invasive way to detect cancer earlier than ever before. This is the cutting edge of precision medicine.

What You’ll Learn in This Episode:

-The science behind liquid biopsies and CTC detection
-How single-cell analysis improves cancer diagnostics
-Mohan’s inspiring journey from rural India to Silicon Valley innovation
-How AI, digital pathology, and biomarker research are transforming oncology
-Why this technology could turn cancer into a manageable, chronic disease

Whether you're a healthcare professional, biotech enthusiast, or someone seeking hope in cancer care, this discussion is packed with insight, science, and inspiration.

Subscribe to MedHeads for more breakthroughs in life sciences, biotechnology, and medical innovation.
Got thoughts or questions? Drop them in the comments—we’d love to hear from you!

#liquidbiopsy #cancerdetection #precisionmedicine #benzotapering #medicalinnovation #ctcdetection #earlycancerdetection #medheadspodcast

Chapters
00:00 From Farming to MedTech Entrepreneur
05:39 Cancer, Immunity, and Genomic Variability
07:00 Transcriptomics: Gene to Protein Insight
10:28 Advancements in Circulating Tumor Cells
15:33 Cancer Treatment Monitoring Thresholds
16:39 CTC Monitoring in Cancer Care
20:51 Global Launch of Medical Technology
23:48 Hope for Managing Chronic Diseases